Partner With Us NRI

Tarsons Products Ltd share Price Today

Company details

6M Return 5.98%
1Y Return -10.71%
Mkt Cap.(Cr) 2,650.19
Volume 239,316
Div Yield 0.41%
OI Chg %
Volume 239,316

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Plastic products firm Tarsons Products announced Q3FY23 results:

  • Q3FY23 & 9MFY23:
    • Revenues for Q3FY23 & 9MFY23 were lower by 13% & 7% respectively, dip in revenues was on account of:
      • Temporary slowdown in the life science industry, since the industry is yet recovering from the after-effects of the covid pandemic.
      • Loss in revenues related to covid pandemic as compared to the previous financial year, however, our conventional business revenues have shown resilience & are expected to pick up.
    • EBITDA margins for the Q3FY23 stood at 43.5% & for 9MFY23 stood at 45%,dip in the margins were on account of:
      • Lower absorption of fixed cost on account of decline in revenues
      • Higher spends on sales promotion, marketing & travelling expenses to fuel future growth in domestic & export markets.
    • Update on our upcoming Capex (New manufacturing capacities at Panchla, West Bengal):
      • Capex plan is as per the schedule and we do not see any major deviation from our timelines.
      • We remain optimistic about the industry growth prospects, with the addition of new product categories & capacity expansion we envisage reaching greater heights.
      • Manufacturing at the new facilities will begin in phases starting from Q2FY24.

Commenting on the Q3 FY23 performance of the company Mr. Rohan Sehgal, Whole Time Director for Tarsons, said: “Our revenues for Q3FY23 were lower by 13% on a YoY basis, this decline was majorly attributable to external macro-economic factors & overall slow down in the life science industry. Impact on revenues was also on account of high base of covid related revenues in FY22, which was replaced by our conventional business to a significant extent in the current financial year.

Due to political uncertainty and growing recessionary trends, our export revenues declined by 17% during the quarter and remained flat for 9MFY23. These are difficult times for not only our industry, but for the entire world, and we are standing firm and attempting to sail through these challenging times.

Our capacity expansion is proceeding smoothly, and commissioning is scheduled for Q2FY24. These capabilities would propel the company's next phase of expansion, which would include the addition of high-value products, which would further strengthen the "Tarsons" brand.

We believe that these market conditions are temporary in nature and in the long term we see the plastic labware market continue to grow both domestically and internationally and so will Tarsons.”

Result PDF

View Other Company Results

Tarsons Products Ltd shares SWOT Analysis

Strengths (6)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Company with Low Debt

Weakness (8)

  • MFs decreased their shareholding last quarter
  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years

Opportunity (2)

  • RSI indicating price strength
  • High Volume, High Gain

Threats (2)

  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 520.8
R2 543.5
R3 566.1


S1 475.4
S2 452.8
S3 430.1
Delivery and volume
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2023-12-21 542.38 302600 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Sell 2023-12-21 543.47 302600 NSE
PLUTUS WEALTH MANAGEMENT LLP Bulk Purchase 2023-09-20 530 1740000 NSE
Name Category Shares


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Tarsons Products Ltd Stocks COMPARISON

Financials( in Cr) Tarsons Products Ltd Central Depository Services (India) Ltd TBO Tek Ltd Indegene Ltd Godrej Agrovet Ltd
Price 498.10 2,114.80 1,606.60 585.50 586.95
% Change 2.57 0.61 2.76 -2.44 -0.83
Mcap Cr 2,650.19 22,099.66 17,445.75 14,009.20 11,281.82
Revenue TTM Cr 283.25 555.09 1,064.59 2,306.13 9,373.68
Net Profit TTM Cr 80.71 275.96 148.49 266.10 295.36
PE TTM 60.64 52.41 81.65 42.87 31.61
1 Year Return -10.71 101.83 14.24 2.56 31.96
ROCE 18.79 31.39 51.92 29.51 10.56
ROE 15.24 23.93 51.90 29.12 10.47

Equity Capital: 569.30 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 35,930.46 -6,140.05
LAST 3M 112,173.55 -45,499.40
LAST 6M 183,830.47 -16,034.02
LAST 12M 290,122.07 99,526.79

Tarsons Products Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • The company was incorporated as Tarsons Products Private Limited on 05 July 1983. The Company was subsequently converted into a public limited company pursuant to a special resolution passed by the Shareholders at the extraordinary general meeting held on 10 May 2021, and the name of the Company was changed to Tarsons Products Limited on 14 June 2021. The Company is engaged in manufacturing and selling of plastic laboratory products and certain scientific instruments.The products find usage in laboratories engaged in research on molecular biology,cell culture,geonomics,proteonomics,immunology etc.The Company caters to both domestic and international markets.The Company has one subsidiary company named Inlabro Pte. Ltd. establised in Republic of Singapore. During the FY2020,the company has converted 2200000 CCDs of Rs 100 each into 8013 class B equity shares of Rs 10 each at a premium of Rs 27444 per share. Pursuant to a resolution passed by the Board on 14 June 2021 and a resolution passed by the Shareholders in the EGM held on 16 June 2021, the Company has sub-divided its face value of equity shares from Rs 10 to Rs 2 each. On 26 June 2021,the company has allotted 49979280 bonus equity shares of Rs 2 each to the shareholders in the ratio of 52:1. During the month of November 2021,the company came out with an Rs 1023.47 crore public issue that comprised of fresh issue of Rs 149.63 crore and an offer for sale of Rs 873.84 crore by promoters and investor.The IPO shares were allotted at the price of Rs 662 per share including a premium of Rs 660 per share.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India(NSE) on 26 November 2021.

Registered Address

Martin Burn Business Park, R No 902 BP-3 Salt Lake Sec-V, Kolkata, West Bengal, 700091

Tel : 91-33-3522 0300
Email : info:tarsons.in; investor:tarsons.com
Website : http://www.tarsons.com

KFin Techologies Ltd

AGM Date (Month) : Jul
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 543399
Book Closure Date (Month) : Jul
BSE Group : B
ISIN : INE144Z01023

FAQ’s on Tarsons Products Ltd Shares

You can buy Tarsons Products Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Tarsons Products Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 14, 2024 03:59 PM the closing price of Tarsons Products Ltd was Rs.498.10.

The latest PE ratio of Tarsons Products Ltd as of Jun 14, 2024 03:59 PM is 60.64

The latest PB ratio of Tarsons Products Ltd as of Jun 14, 2024 03:59 PM is 0.24

The 52-week high of Tarsons Products Ltd share price is Rs. 646.40 while the 52-week low is Rs. 389.10

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 14, 2024 03:59 PM, the market cap of Tarsons Products Ltd stood at Rs. 2,650.19.

Download App

Download Our App

Play Store App Store
market app